LGND

LIGAND PHARMACEUTICALS INC

LGND·53220K504·US·Common Stock·Healthcare - Biotechnology-13D/G

LGND (LIGAND PHARMACEUTICALS INC) is held by 179 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($980.2M), Invesco Ltd. ($379.8M), VANGUARD PORTFOLIO MANAGEMENT LLC ($359.8M). Net institutional sentiment: Mixed. In Q2 2026, 1 member of Congress and 110 funds bought LGND.

179
Holders
(13 Elite)
$5.9B
Total Value
59% (186)
Consensus
110 buying - 76 selling
13F: Insider & Congress: Updated regularly
LGND

Smart Money Verdict

View all
Loading verdict
Held by 179 funds
13 elite

Who's Trading

Source dates: Price Oct 16, 2026 · Insiders Oct 6, 2026 · Activists Aug 13, 2026 · Congress Jun 8, 2026

InsiderRAReardon AndrewSell $5KOct 2, 2026
InsiderRAReardon AndrewSell $600KOct 2, 2026
InsiderRAReardon AndrewSell $467KOct 2, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
3.1M(+4.7%)$980.2M0.0%+163.71%
33
Increased
1.2M(+45.9%)$379.8M0.0%+41.39%
42
Increased
1.1M(+3.5%)$359.8M0.0%+45.20%
32
First report
1M$328.9M0.1%-6.50%
0
Increased
870,950(+2.7%)$275.3M0.0%+45.80%
32
Increased
826,539(+6.1%)$261.3M0.0%+229.20%
33
Increased
762,827(+28.0%)$241.1M0.0%+42.56%
38
Increased
752,044(+31.2%)$237.7M0.1%+49.35%
39
Increased
659,911(+30.8%)$208.6M1.3%+115.83%
61
Increased
589,020(+5.4%)$186.2M0.0%+161.69%
32
Decreased
568,371(-0.9%)$179.7M0.3%+56.31%
0
Increased
429,314(+1.0%)$135.7M0.0%+320.76%
30
Decreased
375,762(-8.7%)$118.8M0.0%+120.56%
0
Decreased
323,245(-15.2%)$102.2M0.0%+79.42%
0
Decreased
291,805(-17.4%)$92.2M0.1%+224.53%
0
Increased
257,389(+1.3%)$81.4M0.0%+232.32%
30
Decreased
253,764(-16.3%)$80.2M0.0%+71.81%
0
Decreased
249,611(-18.5%)$78.9M0.0%+282.67%
0
Increased
248,355(+169x)$78.5M0.1%-6.26%
48
Decreased
210,427(-1.2%)$66.5M0.0%+168.98%
0

Showing 1-20 of 195

1 / 10
LGNDLGNDLIGAND PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used